Trial intelligence / Profile preview

Sirolimus in Beta-thalassemia

NCT04247750Phase 2Unknown

Sponsor
University of Ferrara
Start
Apr 2021
Primary completion
Apr 2022
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of sirolimus in beta thalassemia, sponsored by University of Ferrara. Status: unknown.

02

Drugs

sirolimus
03

Conditions

beta thalassemia

Beyond the preview

Go deeper on NCT04247750.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04247750.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call